Country intelligence
Deals, market moves, science and policy across the platform tagged to Greece.
Legal since 2017, with products finally reaching patients in 2024 and production ramping up.
Market sizing, forecasts, pricing and patient data are available to Prohibition Partners subscribers. View on Prohibition Partners →
Greece rescheduled cannabis in 2017 and built its licensing regime across 2018–2023. Uniquely, flower and extract products are treated as finished pharmaceuticals requiring a rigorous marketing authorisation from EOF; medical imports remain banned.
Only specialist doctors — such as anaesthesiology, neurology, oncology and rheumatology — can initiate prescriptions, with renewals possible under specialist monitoring. Cannabis is a last-resort treatment for approved indications including chemotherapy-related nausea, cancer and neuropathic pain and MS spasticity.
There is no reimbursement; patients pay out of pocket.
Only a few flower strains from a single producer are currently available, with extract products and additional operators expected to follow as marketing authorisations are granted.
Domestic production is expanding as more companies receive operational cultivation licences and build large-scale facilities.
Nothing tagged to Greece yet. Tag deals, studies or articles with this country to see them here and on the map.
